Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHAHRUKH KUREISHY

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1528061108
CMS profile
250423
Location
MCKINNEY, TX

General Payments · PY2018–2024

$5,710.96

  • Reported across 126 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,106.51

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $727.69 31
Education $243.92 3
Travel and Lodging $134.90 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $943.65 17
PY2019 $293.33 22
PY2020 $653.61 8
PY2021 $55.53 3
PY2022 $409.06 14
PY2023 $2,249.27 27
PY2024 $1,106.51 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $26.01 07/23/2024 Food and Beverage Undisputed 01/23/2026 1078918187 CMS
Actelion Pharmaceuticals US, Inc. $78.99 12/18/2024 Education Undisputed 01/23/2026 1078918185 CMS
Amgen Inc. $18.21 03/05/2024 Food and Beverage Undisputed 01/23/2026 1115839720 CMS
ANI Pharmaceuticals, Inc. $20.03 06/12/2024 Food and Beverage Undisputed 01/23/2026 1091163002 CMS
AstraZeneca Pharmaceuticals LP $13.55 01/30/2024 Food and Beverage Undisputed 01/23/2026 1110538773 CMS
AstraZeneca Pharmaceuticals LP $26.24 02/14/2024 Food and Beverage Undisputed 01/23/2026 1110543077 CMS
AstraZeneca Pharmaceuticals LP $28.67 04/17/2024 Food and Beverage Undisputed 01/23/2026 1110530971 CMS
AstraZeneca Pharmaceuticals LP $15.81 04/23/2024 Food and Beverage Undisputed 01/23/2026 1110549112 CMS
AstraZeneca Pharmaceuticals LP $30.20 08/08/2024 Food and Beverage Undisputed 01/23/2026 1110551978 CMS
AstraZeneca Pharmaceuticals LP $24.74 08/13/2024 Food and Beverage Undisputed 01/23/2026 1110553400 CMS
AstraZeneca Pharmaceuticals LP $23.00 08/27/2024 Food and Beverage Undisputed 01/23/2026 1110534462 CMS
AstraZeneca Pharmaceuticals LP $17.71 09/18/2024 Food and Beverage Undisputed 01/23/2026 1110549306 CMS
AstraZeneca Pharmaceuticals LP $20.19 12/04/2024 Food and Beverage Undisputed 01/23/2026 1110554756 CMS
AstraZeneca Pharmaceuticals LP $27.16 12/12/2024 Food and Beverage Undisputed 01/23/2026 1110551916 CMS
AstraZeneca Pharmaceuticals LP $134.90 12/20/2024 Travel and Lodging Undisputed 01/23/2026 1110546029 CMS
AstraZeneca Pharmaceuticals LP $80.17 12/20/2024 Food and Beverage Undisputed 01/23/2026 1110548816 CMS
Axsome Therapeutics, Inc. $19.88 04/16/2024 Food and Beverage Undisputed 01/23/2026 1148320696 CMS
Axsome Therapeutics, Inc. $24.76 05/21/2024 Food and Beverage Undisputed 01/23/2026 1148320698 CMS
Axsome Therapeutics, Inc. $23.21 06/25/2024 Food and Beverage Undisputed 01/23/2026 1148320700 CMS
Axsome Therapeutics, Inc. $24.68 12/10/2024 Food and Beverage Undisputed 01/23/2026 1148320702 CMS
GENZYME CORPORATION $22.47 06/18/2024 Food and Beverage Undisputed 01/23/2026 1139634599 CMS
GENZYME CORPORATION $18.18 07/25/2024 Food and Beverage Undisputed 01/23/2026 1139634603 CMS
GENZYME CORPORATION $18.40 11/25/2024 Food and Beverage Undisputed 01/23/2026 1139634643 CMS
GlaxoSmithKline, LLC. $25.47 02/20/2024 Food and Beverage Undisputed 01/23/2026 1116566794 CMS
GlaxoSmithKline, LLC. $15.73 08/20/2024 Food and Beverage Undisputed 01/23/2026 1116460591 CMS
Grifols USA, LLC $13.84 08/06/2024 Food and Beverage Undisputed 01/23/2026 1124723083 CMS
Grifols USA, LLC $24.21 10/02/2024 Food and Beverage Undisputed 01/23/2026 1124723085 CMS
HARMONY BIOSCIENCES LLC $20.38 05/15/2024 Food and Beverage Undisputed 01/23/2026 1126092024 CMS
HARMONY BIOSCIENCES LLC $84.99 06/18/2024 Education Undisputed 01/23/2026 1126092022 CMS
Inspire Medical Systems, Inc. $19.54 02/01/2024 Food and Beverage Undisputed 01/23/2026 1148070619 CMS
Mylan Specialty L.P. $24.92 07/15/2024 Food and Beverage Undisputed 01/23/2026 1147293215 CMS
Mylan Specialty L.P. $22.19 10/09/2024 Food and Beverage Undisputed 01/23/2026 1147298183 CMS
Regeneron Healthcare Solutions, Inc. $13.40 08/13/2024 Food and Beverage Undisputed 01/23/2026 1114093753 CMS
Regeneron Healthcare Solutions, Inc. $24.74 09/09/2024 Food and Beverage Undisputed 01/23/2026 1114093755 CMS
Regeneron Healthcare Solutions, Inc. $79.94 11/21/2024 Education Undisputed 01/23/2026 1114093757 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.